Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill aims to stop heavy periods caused by fibroids

NCT ID NCT07402369

First seen Feb 15, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study tests a new capsule (CMS-D002) to see if it can reduce heavy menstrual bleeding in women with uterine fibroids. About 120 women aged 18-50 will take either the capsule or a placebo daily for 12 weeks. The main goal is to see if the treatment lowers blood loss to a normal level.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS WITH MENORRHAGIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University First Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.